You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
|
|---|---|
| Published in |
Thyroid Research, March 2023
|
| DOI | 10.1186/s13044-023-00147-7 |
| Pubmed ID | |
| Authors |
Matthias Lang, Thomas Longerich, Chrysanthi Anamaterou |
Mendeley readers
The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 12 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 2 | 17% |
| Student > Ph. D. Student | 1 | 8% |
| Professor | 1 | 8% |
| Other | 1 | 8% |
| Unknown | 7 | 58% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 8% |
| Biochemistry, Genetics and Molecular Biology | 1 | 8% |
| Psychology | 1 | 8% |
| Neuroscience | 1 | 8% |
| Medicine and Dentistry | 1 | 8% |
| Other | 0 | 0% |
| Unknown | 7 | 58% |